310 related articles for article (PubMed ID: 10774479)
21. [Effects of nonsteroidal anti-inflammatory drugs (NSAID) on colorectal polyps in patients with familial adenomatous polyposis: a review of clinical studies].
Akasu T; Kakizoe T
Nihon Geka Gakkai Zasshi; 1998 Jun; 99(6):385-90. PubMed ID: 9695077
[TBL] [Abstract][Full Text] [Related]
22. Celecoxib: new indication. Colorectal cancer: no preventive benefit.
Prescrire Int; 2006 Feb; 15(81):13-5. PubMed ID: 16548099
[TBL] [Abstract][Full Text] [Related]
23. Nonsteroidal anti-inflammatory drugs, COX-2 and colorectal cancer.
Patrignani P
Toxicol Lett; 2000 Mar; 112-113():493-8. PubMed ID: 10720771
[TBL] [Abstract][Full Text] [Related]
24. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
[TBL] [Abstract][Full Text] [Related]
25. Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review.
Asano TK; McLeod RS
Dis Colon Rectum; 2004 May; 47(5):665-73. PubMed ID: 15054679
[TBL] [Abstract][Full Text] [Related]
26. Chemoprevention of colorectal cancer: two steps forward, one step back?
Half EE; Arber N
Future Oncol; 2006 Dec; 2(6):697-704. PubMed ID: 17155896
[TBL] [Abstract][Full Text] [Related]
27. Role of cyclooxygenase-2 in pathogenesis and prevention of colorectal cancer.
Hahn E; Kraus S; Arber N
Dig Dis; 2010; 28(4-5):585-9. PubMed ID: 21088406
[TBL] [Abstract][Full Text] [Related]
28. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer.
Peleg II; Maibach HT; Brown SH; Wilcox CM
Arch Intern Med; 1994 Feb; 154(4):394-9. PubMed ID: 8117171
[TBL] [Abstract][Full Text] [Related]
29. [Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
Florent C; Meary N
Bull Cancer; 2004 May; 91 Spec No():S85-8. PubMed ID: 15239335
[TBL] [Abstract][Full Text] [Related]
30. Chemoprevention of colorectal cancer.
Das D; Arber N; Jankowski JA
Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
[TBL] [Abstract][Full Text] [Related]
31. NSAIDs and colorectal cancer prevention.
Iwama T
J Gastroenterol; 2009; 44 Suppl 19():72-6. PubMed ID: 19148797
[TBL] [Abstract][Full Text] [Related]
32. Chemoprevention with special reference to inherited colorectal cancer.
Lynch PM
Fam Cancer; 2008; 7(1):59-64. PubMed ID: 17680350
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of non-steroidal anti-inflammatory drugs and cancer.
Baron JA
Prog Exp Tumor Res; 2003; 37():1-24. PubMed ID: 12795046
[TBL] [Abstract][Full Text] [Related]
34. [Chemoprevention of familial cancer].
Ishikawa H
Gan To Kagaku Ryoho; 1997 Jun; 24(8):951-7. PubMed ID: 9212803
[TBL] [Abstract][Full Text] [Related]
35. Chemoprevention of colorectal cancer by non-steroidal anti-inflammatory drugs.
Bus PJ; Verspaget HW; Lamers CB; Griffioen G
Scand J Gastroenterol Suppl; 2000; (232):101-4. PubMed ID: 11232485
[TBL] [Abstract][Full Text] [Related]
36. The role of arachidonic acid regulatory enzymes in colorectal disease.
Abir F; Alva S; Kaminski DL; Longo WE
Dis Colon Rectum; 2005 Jul; 48(7):1471-83. PubMed ID: 15868226
[TBL] [Abstract][Full Text] [Related]
37. Non steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomas.
Asano TK; McLeod RS
Cochrane Database Syst Rev; 2004; 2004(2):CD004079. PubMed ID: 15106236
[TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer and nonsteroidal anti-inflammatory drugs.
Smalley WE; DuBois RN
Adv Pharmacol; 1997; 39():1-20. PubMed ID: 9160111
[TBL] [Abstract][Full Text] [Related]
39. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
[TBL] [Abstract][Full Text] [Related]
40. [Oncogenesis humoral mechanisms regulation and NSAIDs ability in prevention of tumors].
Kim VA; Lazebnik LV; Drozdov VN
Eksp Klin Gastroenterol; 2011; (9):3-10. PubMed ID: 22629768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
